Interleukin-10 tested for neuropathic pain in dogs, possibly humans

12/15/2012 | Daily Camera (Boulder, Colo.)

Veterinarian Robert Landry, a diplomate with the American Academy of Pain Management, is teaming up with University of Colorado professor Linda Watkins in a therapeutic trial involving interleukin-10 to treat animals with chronic, debilitating neuropathic pain. Two dogs treated so far have shown positive results, and the treatment may one day prove useful in treating pain in humans. "Our ultimate goal is to find a means by which clinical pain control can be improved so as to relieve human suffering," Watkins said.

View Full Article in:

Daily Camera (Boulder, Colo.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA